Neurocrine Biosciences, Inc. (NBIX)

128.13 -1.51 (-1.16%) USD  |  NASDAQ  |  Mar 06, 16:00
128.18 +0.05 (+0.04%) After-Hours: 20:00
More

Neurocrine Biosciences Return on Invested Capital (3y Median)

Return on Invested Capital (3y Median) Chart

View Return on Invested Capital (3y Median) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (3y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (3y Median) Range, Past 5 Years

View Return on Invested Capital (3y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (3y Median) Benchmarks

View Return on Invested Capital (3y Median) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Edgewise Therapeutics, Inc. Upgrade
Nuvalent, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
CapsoVision, Inc. --